Decreased Cytokine Plasma Levels and Changes in T-Cell Activation Are Associated With Hemodynamic Improvement and Clinical Outcomes After Percutaneous Mitral Commissurotomy in Patients With Rheumatic Mitral Stenosis

Decreased Cytokine Plasma Levels and Changes in T-Cell Activation Are Associated With Hemodynamic Improvement and Clinical Outcomes After Percutaneous Mitral Commissurotomy in Patients With Rheumatic Mitral Stenosis

Mitral stenosis (MS) is a consequence of rheumatic heart disease that leads to heart failure requiring mechanical intervention. Percutaneous mitral commissurotomy (PMC) is the treatment of choice for the intervention, and currently there are no soluble markers associated with hemodynamic improvement...

Full description

Bibliographic Details
Main Authors: Vicente R. Silva, Eula G. A. Neves, Lívia S. Araújo Passos, Flávia Cristina de Melo, Andrea Teixeira-Carvalho, Maria Cecília L. Nassif, Lucas Lodi Junqueira, Elena Aikawa, Walderez O. Dutra, Maria Carmo P. Nunes
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
rheumatic heart disease
mitral stenosis
percutaneous mitral commissurotomy
cytokines
T cells
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.604826/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.604826/full

Similar Items